Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.057 | 0.7 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.048 | 0.7 |
mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |